Corvus Pharmaceuticals, Inc.

Pharmaceutical company · South San Francisco, California, United States · Nasdaq: CRVS

Corvus Pharmaceuticals, Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker CRVS. It has reported private securities offerings to the US SEC, most recently $75 million sold in a notice filed in 2015.

Profile compiled from public records. Is this your company? Request a correction or update

Corvus Pharmaceuticals at a glance

Typepharmaceutical company
HeadquartersSouth San Francisco, California, United States
Earliest incorporation on record2014
Stock listingNasdaq: CRVS
SEC industryPharmaceutical Preparations
SEC CIK1626971

What does Corvus Pharmaceuticals do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $75 million sold (2015).

Frequently asked questions about Corvus Pharmaceuticals

Where is Corvus Pharmaceuticals headquartered?

Corvus Pharmaceuticals, Inc. is headquartered in South San Francisco, California, United States.

What does Corvus Pharmaceuticals do?

Corvus Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Corvus Pharmaceuticals a public company?

Yes. Corvus Pharmaceuticals, Inc. trades on Nasdaq under the ticker CRVS.

When was Corvus Pharmaceuticals founded?

The earliest incorporation on record for Corvus Pharmaceuticals, Inc. is in 2014, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.